Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
1951
Alexander's
ALX
$1.22B
| $1.28M | ﹤0.01% |
5,200
+100
| +2% | +$24.5K |
|
1952
ATN International
ATNI
$235M
| $1.27M | ﹤0.01% |
25,400
+500
| +2% | +$25.1K |
|
|
CKH
1953
DELISTED
Seacor Holdings Inc.
CKH
| $1.27M | ﹤0.01% |
43,800
+1,000
| +2% | +$29.1K |
|
|
TBIO
1954
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.27M | ﹤0.01% |
93,300
+1,400
| +2% | +$19.1K |
|
|
TBI
1955
Trueblue
TBI
$171M
| $1.27M | ﹤0.01% |
81,900
-4,300
| -5% | -$66.6K |
|
1956
Omeros
OMER
$291M
| $1.27M | ﹤0.01% |
125,300
+17,400
| +16% | +$176K |
|
1957
LeMaitre Vascular
LMAT
$2.1B
| $1.27M | ﹤0.01% |
38,900
+1,000
| +3% | +$32.5K |
|
1958
Health Catalyst
HCAT
$229M
| $1.26M | ﹤0.01% |
34,500
+1,200
| +4% | +$43.9K |
|
1959
E.W. Scripps
SSP
$246M
| $1.26M | ﹤0.01% |
110,216
+2,400
| +2% | +$27.5K |
|
1960
Revolution Medicines
RVMD
$7.56B
| $1.26M | ﹤0.01% |
36,200
+9,900
| +38% | +$345K |
|
1961
Acco Brands
ACCO
$357M
| $1.26M | ﹤0.01% |
216,500
| – | – |
|
1962
World Acceptance Corp
WRLD
$904M
| $1.26M | ﹤0.01% |
11,900
-500
| -4% | -$52.8K |
|
1963
GoPro
GPRO
$258M
| $1.26M | ﹤0.01% |
277,100
+7,600
| +3% | +$34.4K |
|
1964
Tootsie Roll Industries
TR
$2.88B
| $1.25M | ﹤0.01% |
47,031
+1,623
| +4% | +$43.3K |
|
1965
PDF Solutions
PDFS
$763M
| $1.25M | ﹤0.01% |
66,900
+2,000
| +3% | +$37.4K |
|
1966
MarineMax
HZO
$545M
| $1.25M | ﹤0.01% |
48,700
+700
| +1% | +$18K |
|
1967
York Water
YORW
$440M
| $1.25M | ﹤0.01% |
29,500
+500
| +2% | +$21.1K |
|
1968
Krystal Biotech
KRYS
$3.98B
| $1.24M | ﹤0.01% |
28,900
+500
| +2% | +$21.5K |
|
|
LGF.A
1969
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.24M | ﹤0.01% |
130,950
| – | – |
|
|
INN
1970
Summit Hotel Properties
INN
$613M
| $1.24M | ﹤0.01% |
239,300
+4,600
| +2% | +$23.8K |
|
|
ANAT
1971
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.24M | ﹤0.01% |
18,313
+300
| +2% | +$20.3K |
|
|
NVEE
1972
DELISTED
NV5 Global
NVEE
| $1.24M | ﹤0.01% |
93,600
| – | – |
|
1973
Kenon Holdings
KEN
$2.43B
| $1.23M | ﹤0.01% |
54,625
| – | – |
|
1974
HealthStream
HSTM
$839M
| $1.23M | ﹤0.01% |
61,500
| – | – |
|
1975
Inogen
INGN
$225M
| $1.23M | ﹤0.01% |
42,500
+700
| +2% | +$20.3K |
|